Find the Right Clinical Trial. For You. For a Loved One.
Susan G. Komen helps people with any stage of breast cancer find and participate in clinical trials, including trials supported by Komen.
This page is continuously being updated to feature different clinical trials – check back soon for more!
In this episode, hear Komen Scholar Alumni and Chief Medical Officer of ASCO, Julie Gralow, M.D., and medical oncologist Erica Mayer, M.D., MPH discuss clinical trials that are testing how different dosing strategies impact treatment adherence, quality of life and outcomes.
Research can take decades to reach the bedside, but what discoveries are just around the corner for patients? Susan G. Komen shares all of this and more through Breast Cancer Breakthroughs, a virtual education series focusing on the new science and technology advancements that are poised to make a difference for patients in the near future. Sign up for Breast Cancer Breakthroughs to never miss an episode.
Spotlight on Clinical Trials
Komen’s Spotlight on Clinical Trials Series is a blog and podcast series that provides the latest information and personal stories from those on the frontlines of recent select breast cancer trials. These highlighted trials encompass a wide range of significant studies that have been instrumental in shaping current treatment strategies for various stages and types of breast cancer.
Susan G. Komen® Patient Care Center
Considering a clinical trial? Our trained navigators are here to answer your questions and guide you through the process of finding and joining a trial. Please call our Breast Cancer Helpline at 1-877 GO KOMEN (1-877-465-6636) to connect with a trained navigator.
Call our Breast Care Helpline to speak with a trained navigator.
1-877 GO KOMEN
or email at clinicaltrialinfo@komen.org
Our Patient Care Center can help you:
- Understand when a clinical trial might be right for you
- Learn how to search and apply for trials
- Compare options and decide which trial fits your needs
- Know what to expect before, during, and after participation
- Access additional educational and support resources
Help discover cures to breast cancer, faster.
Your breast cancer information is as unique as you are. When combined with other people in the ShareForCures community, you provide scientists with a more diverse set of data to make new discoveries, faster.
Clinical Trial Breakthroughs
See how clinical trials are shaping the future of breast cancer care. From new treatments to improved quality of life, explore how research is transforming patient outcomes—and find more progress on our What’s New page.
Learn More About Clinical Trials and Their Impact in our Blog
Explore how groundbreaking breast cancer research translates into real-world treatments and learn about the promising clinical trials shaping the future of care.
Four things to know about clinical trials when you’re diagnosed with breast cancer
A quick guide to understanding clinical trials and how they may be an option in your treatment journey. LEARN MORE >
Shining a Spotlight on Clinical Trials
Learn how clinical trials drive progress and improve outcomes for people with breast cancer. LEARN MORE >
ASCO 2025: Big Advancements Across the Board
Discover the latest clinical breakthroughs shaping the future of breast cancer care. LEARN MORE >
From the Lab to the Clinic: How New Discoveries in Breast Cancer Become Evidence-Based
Stay up to date on the latest research, treatments and discoveries shaping the future of breast cancer care. LEARN MORE >
Shining a Spotlight on Promising Clinical Trials for Young Women
Key insights on how breast cancer can affect younger women differently and what to know about diagnosis, treatment, and care options. LEARN MORE >
Shining a Spotlight on the Benefits of Complementary Therapies for Breast Cancer
A quick look at how clinical trials are exploring complementary therapies like diet, acupuncture and mindfulness to help ease side effects and improve quality of life alongside standard breast cancer care. LEARN MORE >
“Los hispanos representan alrededor del 20 por ciento de la población en los Estados Unidos, pero solo entre el 3 y el 3 y 6% participant en ensayos clinicos de cancer”
– Barbara Segarra Vázquez, M.T., DHSc ha sido especialista de Komen durante más de 18 años
“Hispanic people represent about 20 percent of the population in the United States, but only between 3 and 6 percent participate in cancer clinical trials.”
– Barbara Segarra Vázquez, M.T., DHSc, Komen Scholar and Chair of the Komen Advocates in Science